The US Department of Justice (DOJ) has formally moved to reclassify cannabis as a less harmful Schedule III drug in a move that could have a significant economic impact on the cannabis industry. The Attorney General has submitted a notice of proposed rulemaking which – if given final approval by Drug Enforcement Agency (DEA) – […]
Brent Hull
Brent Hull is an Analyst, working from the Chicago Office, in the Management Consulting and Valuation practice of Ocean Tomo, a part of J.S. Held. Mr. Hull provides strategy, valuation, and transaction advisory assistance to public and private companies in a wide range of industries by applying his knowledge to financial statement analysis, market research, and consultation to develop complex models for our clients. These can then be used to provide financial insight and guidance for M&A, litigation support, and financial strategies.
Contact Brent at [email protected] or +1 224 828 3314